NURULIMAB
UNII 894KSI08XK

Substance Identification & Data

This profile provides standardized clinical and technical data for Nurulimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 894KSI08XK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2168561-20-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
894KSI08XK
CAS Registry Number
2168561-20-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NURULIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11141
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nurulimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NURULIMAB

Common Names & Synonyms

ANTI-CTLA4 MAB (BIOCAD)
NURULIMAB [INN]
NURULIMAB [WHO-DD]

Technical Codes

BCD145
BCD-145